Outset Medical, Inc. ( OM) $ 21.81
-0.60 (-2.83 %)
|Volume Avg.||$420.87 thousand|
|Market Cap||$1.04 B|
|52 Week Range||$19.47 - $60.33|
Outset Medical, Inc. opened the day at $21.81 which is -2.83 % on yesterday's close. Outset Medical, Inc. has a 52 week high of $60.33 and 52 week low of $19.47, which is a difference of $40.86. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $1.04 B and total net profit is $102602000 which means the company is trading at 10.16 times profit to market capitalization. Theoretically, if you were to buy Outset Medical, Inc. for $1.04 B, it would take 15 years to get your money back. Outset Medical, Inc. are in the Medical Devices space which will have a sweet spot and industry standard for net profit multiples.
Outset Medical, Inc. Stock Forecast - Is Outset Medical, Inc. a Buy or Sell?
|DCF Score||Strong Buy|
|PE Score||Strong Sell|
|PB Score||Strong Buy|
Growth and Value
|Net Profit Margin||-1.259|
Valuing Outset Medical, Inc.
|Price Book Value Ratio||2.998||Price To Book Ratio||2.998|
|Price To Sales Ratio||9.395||Price Earnings Ratio||-7.462|
How liquid is Outset Medical, Inc.
|Debt Ratio||0.200||Debt Equity Ratio||0.250|
|Long Term Debt To Capitalization||0.095||Total Debt To Capitalization||0.098|
Latest news about Outset Medical, Inc.
These companies have low share prices and high potential.
Outset Medical, Inc. (OM) delivered earnings and revenue surprises of -1.52% and 0.65%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
This company helps keep patients at home with dialysis treatments.
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the first quarter of 2022 after the close of trading on Wednesday, May 4, 2022. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Leslie Trigg, Chief Executive Officer, and Nabeel Ahmed, Chief Financial Officer, will host a con
These two companies are leading the charge for improved patient outcomes.
About Outset Medical, Inc.
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.